Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 691-698

  Mahler, M ^a   Agmon Levin, N ^b   Van Liempt, M ^a   Shoenfeld, Y ^b,c   Waka, A ^d   Hiepe, F ^d   Swart, A ^e   Gurtler I ^e   Fritzler, M J ^f  

^a Dr Fooke Laboratorien   (Germany)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Rheumatology Clinical Neuss   (Germany)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

C22; ELISA; Ribosomal P; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; RIBOSOMAL P ANTIBODY; UNCLASSIFIED DRUG; EPITOPE; RIBOSOMAL PROTEIN P0; RIBOSOME PROTEIN;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; IMMUNOLOGY; MULTICENTER STUDY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC;

AUTOANTIBODIES; COHORT STUDIES; EPITOPES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; RIBOSOMAL PROTEINS; ROC CURVE;

EID: 84863328633     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1685-x     Document Type: Article

References (39)

1. Miyachi K, Tan EM (1979) Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum 22:87-93 (Pubitemid 9167573)
2. Gerli R, Caponi L (2005) Anti-ribosomal P protein antibodies. Autoimmunity 38:85-92 (Pubitemid 40515008)
3. Bonfa E, Elkon KB (1986) Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum 29:981-985 (Pubitemid 16049257)
4. Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6:119-125 (Pubitemid 46201956)
5. Reichlin M (2006) Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus. Clin Exp Med 6:49-52
6. Mahler M, Kessenbrock K, Szmyrka M, Takasaki Y, Garcia-De La Torre I, Shoenfeld Y, Hiepe F, Shun-le C, von Muhlen CA, Locht H et al (2006) International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 13:77-83
7. Martin AL, Reichlin M (1996) Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus 5:22-29 (Pubitemid 26072425)
8. Ohira H, Takiguchi J, Rai T, Abe K, Yokokawa J, Sato Y, Takeda I, Kanno T (2004) High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 28:137-139 (Pubitemid 38220222)
9. Mahler M, Raijmakers R, Fritzler MJ (2007) Challenges and controversies in autoantibodies associated with systemic rheumatic diseases. Curr Rheumatol Rev 3:67-78 (Pubitemid 46592818)
10. Kessenbrock K, Raijmakers R, Fritzler MJ, Mahler M (2007) Synthetic peptides: the future of patient management in systemic rheumatic diseases? Curr Med Chem 14:2831-2838 (Pubitemid 350130925)
11. Eber T, Chapman J, Shoenfeld Y (2005) Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 14:571-575 (Pubitemid 41296992)
12. Karassa FB, Afeltra A, Ambrozic A, Chang DM, de Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IE, Inanc M et al (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54:312-324 (Pubitemid 43122215)
13. Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, Zhang W, Reichlin M, Shoenfeld Y (2007) Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 56:938-948 (Pubitemid 46399441)
14. Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, Barros LF, Torrealba F, Massardo L, Jacobelli S et al (2007) Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 204:3221-3234
15. Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Bluthner M (2003) Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J Mol Med 81:194-204 (Pubitemid 36470186)
16. Kessenbrock K, Fritzler MJ, Groves M, Eissfeller P, von Mühlen CA, Höpfl P, Mahler M (2007) Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection. J Mol Med 85:953-959 (Pubitemid 47282795)
17. Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA (2010) Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med 88:719-727
18. Bruner BF, Wynn DM, Reichlin M, Harley JB, James JA (2005) Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region. Ann N YAcad Sci 1051:390-403 (Pubitemid 41362769)
19. Mahler M, Kessenbrock K, Raats J, Fritzler MJ (2004) Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J Clin Lab Anal 18:215-223 (Pubitemid 38902622)
20. Agmon-LevinN,Gilburd B, Kivity S, Katz BS, Flitman-Katzevman I, Shoenfeld N, Paran D, Langevitz P, Shoenfeld Y (2009) Antiribosomal- P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. Isr Med Assoc J 11:403-406
21. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, Boki KA, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM (2000) The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 59:99-104 (Pubitemid 30305605)
22. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity-friends or foes? Trends Immunol 30:409-414. Epub 2009 Jul 28. Review
23. Mahler M, Ngo JT, Schulte-Pelkum J, Luettich T, Fritzler MJ (2008) Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Res Ther 10:R131
24. Muro Y, Sugiura K, Morita Y, Tomita Y (2009) Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay. Scand J Rheumatol 38:460-463
25. Paller MS, Moore WS, Tan E, Schrier RW(1983) Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course. Am J Med 75:529-533 (Pubitemid 13005790)
26. Sugisaki K, Takeda I, Kanno T, Nogai S, Abe K, Sakuma H, Kasukawa R (2002) An anti-nuclear antibody-negative patient with systemic lupus erythematosus (SLE) accompanied with antiribosomal P antibody (anti-P). Intern Med 41:1047-1051 (Pubitemid 35423099)
27. Mahler M, Fritzler MJ, Blüthner M (2005) Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Res Ther 7:R19-R29
28. Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288-291 (Pubitemid 34118775)
29. Wasmuth JC, Grün B, Terjung B, Homrighausen A, Spengler U (2004) ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus. Clin Chem 50:2169-2171 (Pubitemid 39425863)
30. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32:79-84
31. Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K (2010) Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 352:147-152
32. Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S et al (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58:843-853 (Pubitemid 351364883)
33. Haddouk S, Marzouk S, Jallouli M, Fourati H, Frigui M, Hmida YB, Koubaa F, Sellami W, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H (2009) Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford). 48:953-957
34. Pipili C, Sfritzeri A, Cholongitas E (2009) Deforming arthropathy in SLE: review in the literature apropos of one case. Rheumatol Int 29:1219-1221
35. Hanly JG, Su L, Farewell V, Fritzler MJ (2010) Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 358:75-80
36. Lin JL, Dubljevic V, Fritzler MJ, Toh BH (2005) Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus. Clin Exp Immunol 141:155-164 (Pubitemid 40904653)
37. Vercammen M, Meirlaen P, Sennesael J, Velkeniers B, T'Kint S, Verbruggen L, Haentjens P, Broodtaerts L, Demanet C, De Waele M (2007) Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clin Chem Lab Med 45:505-512 (Pubitemid 46632217)
38. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277 (Pubitemid 13221242)
39. Bossuyt X (2009) Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 8:543-548